Pacer Data & Infra Real Estate ETF vs Twist Bioscience Corp — how do they compare? Pacer Data & Infra Real Estate ETF trades at $28.24 (market cap $296.73M), while Twist Bioscience Corp trades at $155.76 (market cap $10.08B). The key difference: Twist Bioscience Corp is far larger — about 34× Pacer Data & Infra Real Estate ETF's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Pacer Data & Infra Real Estate ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Pacer Data & Infra Real Estate ETF for 10 Days and Twist Bioscience Corp for 27 Days on average.
| SRVR | TWST | |
|---|---|---|
Market Cap | $296.73M | $10.08B |
Volume | 243,654 | 4,229,037 |
Sector | Sector/Thematic | Health |
52-Week High | $35.74 | $205.00 |
52-Week Low | $28.17 | $25.45 |
Typical Hold Time | 10 Days | 27 Days |
Enterprise Value | — | $10.01B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TWST trades at $155.65, down 6.78% today, reflecting a bearish technical signal and recent earnings misses. Revenue growth is strong, rising to $376.57M in 2025, but profitability remains elusive with a net income margin of -31.66%. The company's partnership with Lilly TuneLab for AI-driven drug discovery has generated positive news flow, yet cash flow remains negative, and the stock trades at elevated valuation multiples like P/S of 22.01.
The outlook is mixed: strong analyst buy-side consensus (73% Buy) and strategic AI partnerships offer growth potential, but persistent losses, high cash burn, and bearish technicals pose significant risks. Investors face a trade-off between long-term innovation prospects and near-term financial instability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Pacer Data & Infra Real Estate ETF seeks exposure to real estate companies that own digital infrastructure assets. Its holdings may include data centers, cell towers, fiber networks, and other connectivity-related real estate.
Read more on SRVR →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →